Market Intelligence
Get comprehensive and up-to-date information about the Healthcare market and the export potential for your products and services!
For more information about our market research services, please contact our specialists for the relevant industry sectors.
The European Commission has taken action in the past several weeks to tackle the PRC’s unfair market practices
India’s $12B MedTech market is set to hit $50B by 2030, offering big opportunities for U.S. firms—despite regulatory, pricing, and IP challenges.
Peru’s Law 32319 allows expedited registration of pharmaceuticals from countries with strong health monitoring, giving U.S. exporters quicker market access.
The new Ghanaian Government has announced initiatives to reform Ghana’s healthcare system, including a trust fund aimed at bridging healthcare financing.
CABEI-funded turnkey hospital tender in Guatemala, covering design, construction, and equipment opportunity for US companies.
Colombia’s FDA launches new platform to streamline sanitary registrations, permits, and notifications.
In Panama, the registration process for medical devices is overseen by the Ministry of Health (Ministerio de Salud or MINSA).
The Israeli Ministry of Health has launched new, quicker and more efficient registration tracks.
Artificial Intelligence is transforming Malaysia’s healthcare with improved diagnostics, early cancer detection, and cost savings.
The Serbian Healthcare Fund is exploring partnerships with U.S. pharmaceutical producers to address potential market shortages.
The pet care industry in Panama is growing, driven by increasing pet ownership, a rising middle class, and a growing awareness of animal health and wellness.
Law 419, enacted on February 1, 2024, regulates importation, manufacturing, commercialization, and registration of medicines and medical devices in Panama.
INVIMA has launched a Contingency Plan to accelerate the approval of sanitary registrations and pharmaceutical procedures.
Thailand’s Minister of Public Health makes reducing non-communicable diseases a top priority, increasing business opportunities for U.S. healthcare companies.
Biopharmaceutical Production in South Africa